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Abstract: The extracellular matrix of solid tumors presents a transport barrier that restricts 
nanoparticle penetration, thereby limiting the efﬁ  cacy of nano-sized delivery vehicles for cancer 
imaging and therapy. In this study, the effect of nanoparticle size and collagenase treatment on 
penetration of carboxylated polystyrene nanoparticles was systematically assessed in a mul-
ticellular spheroid model. Penetration of the nanoparticles into the spheroid core was limited 
to particles smaller than 100 nm. Collagenase treatment of spheroids resulted in signiﬁ  cantly 
increased penetration of nanoparticles up to 100 nm with only a minor increase in particle 
penetration observed for particles larger than 100 nm. Collagenase was immobilized onto the 
surface of nanoparticles for site-speciﬁ  c degradation of ECM proteins. Collagenase-coated, 
100 nm nanoparticles demonstrated a 4-fold increase in the number of particles delivered to 
the spheroid core compared with control nanoparticles. Thus, nanoparticle delivery to solid 
tumors may be substantially improved by the incorporation of ECM-modulating enzymes in 
the delivery formulation.
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Introduction
Nanoparticulate delivery vehicles such as polymer-small molecule conjugates, lipo-
somes, and viruses offer distinct advantages for anti-cancer treatment approaches, 
including selective accumulation in tumor areas due to the enhanced permeability 
and retention (EPR) effect, cocktail packaging of molecular imaging and therapeutic 
agents, and delivery of macromolecules such as nucleic acids and proteins. Typical 
sizes of nanoparticles being developed for clinical applications range from 2 nm to 
200 nm (Portney and Ozkan 2006). Effective treatment of solid tumors requires that 
the nanoparticles reach as many cells within the tumor as possible, but penetration into 
tumor tissue is a signiﬁ  cant problem for relatively large particles such as liposomes 
and viruses that are directly injected in solid tumors (Pluen et al 2001; Grill et al 2002; 
Kostarelos et al 2004). 
The limited spread of nanoparticles in solid tumors following extravasation can be 
attributed to binding within tumor tissue, increased interstitial ﬂ  uid pressure caused 
by leaky vasculature and poor lymphatic drainage, and torturosity and hindered 
diffusion due to cell packing and the extracellular matrix (ECM) (Netti et al 2000; 
Jain 2001; Kuppen et al 2001; Davies et al 2001; Grantab et al 2006). To minimize 
the “binding site barrier”, nanoparticles can be surface-modiﬁ  ed with non-fouling 
materials such as polyethylene glycol to reduce this non-speciﬁ  c binding (Kaul and 
Amiji 2005). Previous work has demonstrated that eliminating the pressure gradi-
ent within solid tumors results in minimal enhancement in macromolecule delivery 
suggesting that high interstitial pressure within solid tumors is not the only major 
barrier to penetration of macromolecules (Flessner et al 2005). Several recent studies International Journal of Nanomedicine 2007:2(2) 266
Goodman et al
reveal that the ECM provides a major barrier to antibody 
penetration in solid tumors (Netti et al 2000; Davies et al 
2002; Choi et al 2006). Modulation of the ECM by intrave-
nous injection of protease enzymes into xenograft tumors 
increases the spread of macromolecules such as antibodies, 
and direct injection of protease enzymes increases the pen-
etration of nanoparticles such as viruses administered to the 
tumor (Eikenes et al 2004; McKee et al 2006). The relative 
effect of various components of the ECM most likely varies 
with tumor type, as ECM differs among tumors of different 
type and location (Pluen et al 2001), but several studies 
have shown that collagenase improves macromolecular 
penetration depth (Kuriyama et al 2001; Alexandrakis 
et al 2004; Eikenes et al 2004; Choi et al 2006; McKee et al 
2006), while treatment with hyaluronidase yielded mixed 
results (Alexandrakis et al 2004; Eikenes et al 2005; Choi 
et al 2006). These in vivo studies demonstrate that disrup-
tion of the ECM can signiﬁ  cantly improve the efﬁ  cacy 
of several therapeutic systems in solid tumors. However, 
the applicability of this approach to the broad class of 
nanoparticulate delivery vehicles is not yet clear.
The goal of this work was to investigate the effects 
of nanoparticle size and ECM integrity on nanoparticle 
penetration. The diffusion in collagen gels and solid tumors 
of macromolecules that are typically an order of magnitude 
smaller than nanoparticles used for drug delivery has been 
studied using high molecular weight dextrans and proteins 
as tracer molecules (Ramanujan et al 2002; Alexandrakis 
et al 2004; Dreher et al 2006). However, the limitations of 
nanoparticle penetration have not yet been systematically 
assessed. In this study, penetration of model nanoparticles 
ranging from 20 to 200 nm in diameter was assessed in a 
three-dimensional, multicellular spheroid tumor model. 
Multicellular spheroids (MCS) are cultured cells grown in a 
three-dimensional, spherical arrangement and provide tissue-
like cell-cell interactions and extracellular matrix production 
(Sutherland 1988). In addition, the effect of ECM modulation 
on nanoparticle penetration in spheroids was investigated. 
Treatment of spheroids with collagenase either in solution 
or immobilized on the nanoparticle surface resulted in 
signiﬁ  cantly increased nanoparticle penetration. 
Materials and methods
Cell culture and multicellular spheroid 
formation
Cell culture media, serum, and supplements were purchased 
from Mediatech (Herndon, VA). SiHa (human cervical 
carcinoma) cells were maintained in monolayer cultures 
prior to spheroid formation. To initiate spheroid growth, 
monolayer cells were trypsinized, and 107 cells were added 
to a 250 ml spinner ﬂ  ask (Belco, Vineland, NJ) containing 
200 ml complete media (MEM media with 10% FBS and 
antibiotic-antimytotic solution) that was pre-equilibrated to 
5% CO2. Cells were stirred in the sealed spinner ﬂ  ask at 150 
RPM in an incubator at 37 °C. After 3 days, 150 ml of media 
was removed from the spinner ﬂ  ask and replaced with 150 
ml of fresh media. The media was then replaced daily with 
150 ml MEM containing 5% FBS and antibiotics. 
Nanoparticle characterization
The sizes of ﬂ  uorescently-labeled, carboxylated, 20, 40, 100, 
and 200 nm polystyrene beads (Invitrogen) were analyzed 
by dynamic light scattering (DLS) using a ZetaPALS 
analyzer (Brookhaven Instruments, Holtsville, NY) and 
by transmission electron microscopy (TEM). For TEM of 
polystyrene particles, 10 μl of bead stock solutions were 
spotted directly onto TEM grids, allowed to adsorb for 
5 min followed by removal of residual ﬂ  uid. To determine if 
particles aggregated under experimental conditions, particles 
were sized in deionized water and in OptiMEM, incubated 
for 3 h at 37 °C, and resized.
Nanoparticle delivery to multicellular 
spheroids
Spheroids with diameters between 400–500 μm were 
obtained after approximately 10–14 days of growth. For each 
experiment, ~30 spheroids were handpicked with a Pasteur 
pipette and transferred to a 1.5 ml siliconized tube. Media was 
exchanged to OptiMEM reduced serum media (Gibco, Grand 
Island, NY). Appropriate concentrations of collagenase (from 
Clostridium histolyticum, 0.74 U/mg, Sigma) were added to 
the spheroids followed by addition of ﬂ  uorescently labeled 
polystyrene beads (Invitrogen, Carlsbad, CA). The beads 
were added to a ﬁ  nal concentration of 7.58 × 1011 beads/ml 
for all sizes tested, and spheroids were rotated at 5 RPM for 
5 h at 37 °C. The media was then removed by aspiration 
and spheroids were washed with phosphate buffered saline 
(pH 7.4) before further processing. For determination of 
relative nanoparticle concentrations in the outer cell layers 
compared with the core of the spheroids, the outer cell layers 
were removed from the spheroids using a procedure similar 
to that applied previously for sequential trypsinization of 
spheroids (Oloumi et al 2000). Spheroids were washed 3× 
with PBS + 2% FBS followed by the addition of 1 ml of 
0.25% Trypsin or PBS (for controls). Spheroids were then International Journal of Nanomedicine 2007:2(2) 267
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placed in a 12-well TC dish and rotated at 130 rpm for 20 min 
at 37 °C. Spheroids were imaged by epiﬂ  uorescence micros-
copy to conﬁ  rm that the outer cell layers were removed. The 
trypsin solution was aspirated off the spheroids and replaced 
with MEM + 10% FBS. The spheroids were transferred to 1.5 
ml centrifuge tubes, washed twice with 1 ml PBS + 2% FBS, 
and resuspended in 300 μl PBS. The spheroids were broken 
up with vigorous pipetting and the solution was homogenized 
by sonicating 2× for 10 sec at 8–9 watts using a probe tip 
sonicator (Sonic Dismebrator 60, Fisher). The ﬂ  uorescence 
of the sonicated cells was then measured by placing 250 μl of 
each sample in a 96-well plate and reading the ﬂ  uorescence 
using a Tecan (Zurich, Switzerland) Saﬁ  re2 plate reader. The 
number of nanoparticles associated with the spheroid core 
(spheroids exposed to trypsin) and total spheroids (control 
spheroids exposed to PBS) was determined by comparison 
to a standard curve made by measuring ﬂ  uorescence emis-
sion of nanoparticles prepared at known concentrations in 
cell lysate. The percentage of nanoparticles reaching the 
spheroid cores was determined by dividing the number of 
nanoparticles associated with trypsinized spheroid by the 
number of nanoparticles associated with spheroids that had 
not been exposed to trypsin.
Preparation and characterization 
of collagenase-coated nanoparticles
Polystyrene beads were coated with protein by incubating 
75 μl of 100 nm bead stock (3.64 × 1014 beads/ml stock) 
with 375 μl of 5 mg/ml collagenase or albumin in H2O for 
12 hours. Beads were then sedimented by centrifugation at 
~20,000 g and washed twice to remove free protein. Rela-
tive bead concentration was determined by measuring the 
ﬂ  uorescence of each bead sample using a Saﬁ  re2 ﬂ  uorimeter 
(Tecan, Research Triangle Park, NC) and comparing to a 
standard curve. The activity of the collagenase adsorbed to 
the bead surface was determined using a collagenase I assay 
kit following the manufacturer’s instructions (Chemicon 
International, Temecula, CA; kit ECM710).
Fluorescence imaging and image analysis
For analysis of nanoparticle penetration by fluorescent 
imaging, spheroids were transferred to a cryomold, covered in 
optimal cutting temperature (O.C.T.) compound (Tissue-Tek, 
Torrance, CA), ﬂ  ash frozen in liquid nitrogen, and processed 
by cutting 8 μm sections using a CM1900 cryostat (Leica, 
Wetzlar, Germany). Fluorescent images of spheroid sections 
were obtained with a Nikon Eclipse TE2000-U inverted 
microscope (Meridian Instrument, Kent, WA) attached to 
a CoolSnapHQ CCD camera (Photometrics, Tucson, AZ) 
and analyzed using Metamorph software. To assess core 
ﬂ  uorescence, individual images of spheroid sections were 
outlined manually and the outline of the spheroids was 
projected 40 μm into the spheroid using Metamorph. The 
integrated pixel intensity within the projected area was then 
normalized by spheroid area, and baseline ﬂ  uorescence from 
spheroids not exposed to ﬂ  uorescent beads was subtracted 
from the normalized signal. Samples were run in duplicate 
and at least ﬁ  ve independent central spheroid sections were 
analyzed for each sample. 
Flow cytometry
Cells were prepared for ﬂ  ow cytometry analysis by washing 
spheroids twice with PBS + 2% FBS and once with PBS 
followed by trypsinization with 0.25% trypsin in Hank’s 
Balanced salt solution (HBSS) for 25 min at 37 °C. Trypsin 
was aspirated from the cells followed by two washes with 
PBS + 2% FBS, and propidium iodide was added to resus-
pended cells to a ﬁ  nal concentration of 2 μg/ml. Cells were 
then analyzed using an LSR ﬂ  ow cytometer (BD Biosciences, 
San Jose, CA). For analysis, live cells were identiﬁ  ed using 
forward and side scatter signal and then assessed for prop-
idium iodide signal.
Immunostaining
Spheroid sections were stained for collagen using a poly-
clonal rabbit anti-human collagen antibody that was raised 
against collagens I-V (AbCam, Cambridge, MA; 1:100) 
and visualized with a AlexaFluor488 goat anti-rabbit IgG 
(H + L) secondary antibody (Invitrogen; 1:50). Cell nuclei 
were stained with a 1 μg/ml solution of DAPI for 30 min and 
sections were preserved using ProLong antifade solution (In-
vitrogen). Images of collagen stained samples were obtained 
using a Zeiss LSM 510 NLO inverted confocal microscope 
(NTUF University of Washington, Seattle, WA). 
Transmission electron microscopy
Spheroid sections for TEM analysis were prepared by ﬁ  xing 
spheroids in half strength Karnovsky’s ﬁ  xative (2% parafor-
maldehyde, 2.5% gluteraldehyde, 0.1 M cocadylate buffer, 
3 mM CaCl2, at pH 7.3) overnight followed by post ﬁ  xing in 
1.0% OsO4 for 1 h. The spheroids were then stained with 2% 
uranyl acetate, rinsed and dehydrated with absolute ethanol 
and embedded in Eponate resin (Ted Pella, Redding CA). 
Sections were cut using a Reichert Ultracut E microtome 
and mounted on 150 mesh 0.25% formvar coated rhodium/
copper grids. The sections were stained with uranyl acetate International Journal of Nanomedicine 2007:2(2) 268
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and lead citrate and imaged with a JEM 1200EX II transmis-
sion electron microscope (JOEL Ltd, Tokyo, Japan). Tissue 
processing and imaging was performed at the University 
of Washington Pathology Electron Microscopy Resource 
Center (Seattle, WA).
Statistical analysis
Statistical analysis was performed using unpaired Students’ 
t tests. Results were considered statistically signiﬁ  cant with 
a p value <0.05.
Results
Particle size conﬁ  rmation by DLS and TEM
The particle size of nanoparticles was determined by 
electron microscopy and light scattering analysis. Elec-
tron microscopy revealed that the 20 and 40 nm nanopar-
ticles were more polydisperse than the 100 and 200 nm 
nanoparticles, but conﬁ  rmed that four separate particle 
sizes were represented in these studies (Figure 1). Dynamic 
light scattering measurements of nanoparticles yielded 
mean diameters of 23.1 (±0.9) nm, 39.4 (±3.2) nm, 103.5 
(±6.4) nm, and 209.0 (±35.4) nm for nanoparticles referred 
to hereafter as 20, 40, 100, and 200 nm respectively. The 
stability of nanoparticles under experimental conditions was 
assessed by incubation of the nanoparticles in OptiMEM 
for 3 hours followed by measurement of particle size. Light 
scattering measurements indicated that particles showed 
minor aggregation under experimental conditions, with 
an increase of 11.1 (±1.8)% in mean diameter for 200 nm 
particles, an 8.5 (±4.7)% increase for 100 nm particles and 
no signiﬁ  cant change in size for 20 nm, and 40 nm particles 
after incubation in OptiMEM. 
Optimizing collagenase concentration
The effect of ECM components on nanoparticle diffu-
sion in tissue was assessed by degrading the fibrillar 
ECM protein, collagen, in multicellular spheroids (MCS) 
during exposure to nanoparticles. Spheroid integrity as 
a function of collagenase concentration was studied by 
microscopy. Treatment of spheroids with 0.1 mg/ml col-
lagenase resulted in a slight loosening of cells at the outer 
spheroid perimeter, whereas treatment with 1.0 mg/ml 
of collagenase signiﬁ  cantly affected spheroid architec-
ture (Figure 2). Spheroids were also treated with various 
concentrations of collagenase along with 40 nm ﬂ  uores-
cently labeled nanoparticles for 5 hours and particle penetra-
tion was analyzed by ﬂ  uorescence microscopy and image 
analysis of sectioned spheroids. Nanoparticle penetration 
increased with collagenase concentration up to 0.5 mg/ml, 
with the ﬁ  rst major increase in ﬂ  uorescence occurring at 
a concentration of 0.1 mg/ml, where a 4-fold increase in 
nanoparticle ﬂ  uorescence was observed (Figure 3). Colla-
genase-treated spheroids were also trypsinized to single-cell 
suspension and cell viability assessed by propidium iodide 
exclusion with ﬂ  ow cytometry analysis. No signiﬁ  cant in-
crease in propidium iodide signal was detected in the gated 
cell population with any samples treated with collagenase 
(up to 2.5 mg/ml collagenase; data not shown). Based on 
these studies, 0.1 mg/ml collagenase was determined to 
be the optimum collagenase concentration that impacts 
nanoparticle penetration without a concomitant loss of 
overall spheroid integrity and was used for subsequent 
studies with various sized nanoparticles.
Collagen staining and degradation 
of collagen by collagenase
In order to verify the presence of ECM in SiHa multicellular 
spheroids and the effect of collagenase treatment, spher-
oid sections were stained with antibodies that recognize 
collagens I-V and imaged by confocal microscopy. Collagen 
labeling conﬁ  rmed signiﬁ  cant collagen content in the SiHa 
multicellular spheroids (Figure 4A). Spheroids treated with 
0.1 mg/ml of collagenase from Clostridium histolyticum, 
(0.74 U/mg), which cleaves human collagen types I, II, 
and III (Vanderrest et al 1977) resulted in a signiﬁ  cant 
decrease in collagen content following collagenase treatment 
(Figure 4B). No signal was observed with controls without 
the primary collagen antibody (data not shown). 
Figure 1 TEM images of polystyrene nanoparticles. Particle sizes shown are 20, 40, 
100, and 200 nm (A–D, respectively). The scale bar represents 100 nm.International Journal of Nanomedicine 2007:2(2) 269
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Effect of nanoparticle size on penetration 
in MCS
The effect of nanoparticle size on penetration in a three-
dimensional cell culture model was assessed by incubating 
nanoparticles of various sizes (20, 40, 100, and 200 nm 
in diameter) with multicellular spheroids and quantifying 
particle association. Because a predominate percentage 
of the nanoparticles remain in the outer few cell layers, 
variations in ﬂ  uorescence from these cells mask subtle 
changes in the penetration to the spheroid. Therefore, the 
penetration of nanoparticles into the “core” of untreated 
spheroids was investigated by removing the outer cell layers 
by gentle trypsinization of spheroids and analyzing the 
ﬂ  uorescence remaining in the core of the spheroid. Fluores-
cence imaging of the spheroids before and after trypsination 
conﬁ  rmed removal of the bright outer cell layers as well as 
the morphological integrity of the remaining spheroid core. 
The number of nanoparticles associated with the spheroids 
was determined by comparison to ﬂ  uorescence standards 
made with cell lysates containing known nanoparticle 
concentrations. Results are shown as the percentage of 
nanoparticles in the spheroid core, calculated by dividing 
the number of nanoparticles associated with the spheroid 
cores by the number of nanoparticles in whole spheroids 
(without removal of outer cell layers). Our results show 
that the percentage of particles that enter the spheroid core 
decreases as particle size increase (Figure 5). The 20 nm and 
40 nm nanoparticles penetrate effectively (57% and 32%, 
respectively, of spheroid-associated nanoparticles in the 
spheroid core) whereas 100 nm and 200 nm nanoparticles 
demonstrate restricted penetration (<5% of spheroid-
associated nanoparticles in the spheroid core). 
Effects of collagenase on nanoparticle 
penetration
The effect of collagen degradation on nanoparticle 
penetration was investigated by exposing the spheroids to 
ﬂ  uorescently-labeled nanoparticles (20–200 nm in diameter) 
in the presence and absence of collagenase. Nanoparticle 
distributions in untreated spheroid cryosections are 
shown in Figure 6A (row 1). Some diffuse ﬂ  uorescence is 
Figure 2 Optimization of collagenase concentration for nanoparticle delivery to multicellular spheroids. Brightﬁ  eld images of spheroid integrity after collagenase treatment are 
shown in at low magniﬁ  cation (A, scale bar 150 μm) and high magniﬁ  cation (B, scale bar 50 μm). Images correspond to collagenase concentrations of 0, 0.1, and 1 mg/ml. 
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Figure 3 Quantiﬁ  cation of nanoparticle association from spheroids co-incubated 
for 5 hours with 40 nm, ﬂ  uorescently-labeled beads and various concentrations of 
collagenase are presented as the ratio of integrated spheroid section ﬂ  uorescence 
compared with spheroids exposed to nanoparticles in the absence of collagenase 
treatment.International Journal of Nanomedicine 2007:2(2) 270
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observed in the interior of spheroids exposed to 20 and 40 
nm nanoparticles without collagenase, but nanoparticles 
were predominantly restricted to the spheroid periphery for 
all sizes. Collagenase treatment (0.1 mg/ml) of spheroids 
signiﬁ  cantly increased the delivery of 20 nm and 40 nm 
nanoparticles to the MCS; nanoparticle ﬂ  uorescence was 
clearly distributed throughout the treated spheroid sections 
(Figure 6A, row 2). A slight increase in ﬂ  uorescence was 
observed with 100 nm and 200 nm nanoparticles following 
collagenase treatment but not to the extent of the smaller 
nanoparticles. No signiﬁ  cant increase in cell autoﬂ  uorescence 
was induced by collagenase treatment. 
In order to quantify the effect of collagenase treatment 
on nanoparticle penetration, the ﬂ  uorescence intensity of the 
spheroid sections was integrated using Metamorph software. 
Some cells from the outermost layers of the spheroid were 
likely dissociated from the spheroid following collagenase 
treatment. To eliminate contributions and variations from 
this outer layer, the core ﬂ  uorescence per unit area was de-
termined by integrating the ﬂ  uorescence from the area of the 
spheroid up to the outer 40 μm rim and normalizing by the 
section area. It is also important to note that the measured 
ﬂ  uorescence emission intensity per particle of the 40, 100, 
and 200 nm nanoparticles are 7-fold, 180-fold, and 1900-fold 
higher than the emission intensity of 20 nm nanoparticles, 
respectively. To adjust for this difference, the effect of col-
lagenase treatment on nanoparticle penetration is reported 
as the ratio of the ﬂ  uorescence per unit area of collagenase-
treated spheroid sections to the ﬂ  uorescence per unit area of 
untreated spheroid sections for each nanoparticle size. Col-
lagenase treatment increased the penetration of 20 nm and 
40 nm nanoparticles by 6.9 and 11.6 fold, respectively, while 
smaller effects were detected for the 100 nm and 200 nm 
nanoparticles (3.2- and 1.5-fold, respectively; Figure 6B).
TEM imaging of nanoparticle penetration
Sections of nanoparticle-treated spheroids were imaged by 
transmission electron microscopy in order to elucidate the 
mechanism of increased nanoparticle penetration. Electron 
micrographs revealed that SiHa cells are tightly packed in 
the spheroid, with many cells connected to neighboring cells 
via tight junctions. The 100 nm nanoparticles were easily 
Figure 4 Collagen-stained spheroid cryosections in the untreated (A) and collagenase-treated (B) spheroids. Treated spheroids were exposed to 0.1 mg/ml of collagenase 
for 5 hours prior to sectioning and staining. Secondary antibody signal, indicating collagen staining, is shown in green and the nuclear stain, DAPI, is shown in blue. (Scale bar 
is 50 μm) 
Figure 5 Percentage of spheroid-associated nanoparticles that penetrate past 
the outer few cell layers as a function of nanoparticle size. Spheroid cores were 
isolated by removing the outer cell layers of the spheroids with gentle trypsin-
ization. The number of nanoparticles associated with the whole spheroids and 
spheroid cores was quantiﬁ  ed by ﬂ  uorescence measurements. 
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identiﬁ  able at high magniﬁ  cation by TEM and were found 
both in the intracellular and extracellular space (Figure 7). 
The extracellular particles were found mainly in paracellular 
gaps (Figure 7A) and at the surface of the spheroid (Figure 
7B) while the intracellular particles were trapped in mem-
brane bound vesicles (Figure 7C). The 40 nm nanoparticles 
were also observed in extracellular spaces between cells 
(not shown); however, internalized 40 nm nanoparticles 
and 20 nm nanoparticles were difﬁ  cult to distinguish from 
cellular components by TEM.
Collagenase-coated nanoparticles exhibit 
improved penetration into spheroid tissue
There are several drawbacks to administration of free 
collagenase as an adjuvant to nanoparticle delivery. A more 
attractive option is the incorporation of active collagenase into 
the nanoparticle itself. A nanoparticle targeted to tumor tissue 
could mediate localized ECM degradation, thus reducing side 
effects from systemic or intratumoral collagenase delivery. 
In order to assess the effect of localized collagenase delivery, 
protein was adsorbed onto the nanoparticles by incubating 
the polystyrene nanoparticles with collagenase or albumin 
(as a control) solutions and removing free protein through 
multiple centrifugation washes. With this method, >99% of 
unadsorbed protein was removed.
To conﬁ  rm that active collagenase was adsorbed on the 
nanoparticle surfaces, a colorimetric assay was used to quantify 
collagenase activity. The coated nanoparticles showed collage-
nase activity equivalent to ~0.33 μg/ml free collagenase, while 
no activity was observed with controls of BSA coated nanopar-
ticles or nanoparticles alone. Incubation of spheroids with 100 
nm collagenase-coated nanoparticles resulted in a signiﬁ  cant 
increase (~4-fold) in spheroid core ﬂ  uorescence compared with 
albumin-coated nanoparticles (Figure 8). There was no increase 
in core ﬂ  uorescence when equivalent amounts of collagenase 
were added to albumin coated nanoparticles, where equivalent 
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Figure 6. A. Fluorescence microscopy images of cryosections from spheroids co-incubated with various sizes of ﬂ  uorescently-labeled nanoparticles with (“treated”), or 
without (“untreated”) 0.1 mg/mL collagenase.  Scale bar represents 200 μm. B. The ratio of integrated ﬂ  uorescence from nanoparticles in the collagenase-treated versus 
untreated spheroid sections.
Figure 7. Representative TEM images of 100 nm nanoparticles in SiHa multicellular spheroid sections. Arrows indicate the location of the nanoparticles. The nanoparticles 
were found in the paracellular space (A), at the surface of the spheroids (B), and in intercellular vesicular structures (C).  Bar = 200 nm. International Journal of Nanomedicine 2007:2(2) 272
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protein refers to the small amount of residual protein remaining 
after nanoparticle puriﬁ  cation. Dynamic light scattering con-
ﬁ  rmed that particle size differences between albumin-coated and 
collagenase-coated nanoparticles were negligible with measured 
sizes of 110 (±1.2) nm for albumin-coated and 115 (±1.7) nm 
for collagenase-coated nanoparticles.
Discussion
Our previous work along with other reports in the literature 
have demonstrated that many nanoparticle-based systems for 
cancer therapy have limited accumulation in tumor areas, in 
large part due to inefﬁ  cient tumor penetration (Yuan et al 1994; 
Graff et al 2004; Pun et al 2004). The limited transport of 
therapeutic small molecules and macromolecules and resulting 
inaccessibility to most target cells has been identiﬁ  ed as a key 
barrier to drug efﬁ  cacy (Jain 2001; Tannock et al 2002; Hicks 
et al 2003). Thus, the diffusion of inert macromolecular trac-
ers such as dextran and albumin with sizes up to ~10 nm has 
been investigated in collagen gels and solid tumors in vivo 
(Nugent and Jain 1984; Ramanujan et al 2002; Dreher et al 
2006). However, to our knowledge, a systematic study of 
larger nanoparticles and the effect of ECM integrity has not 
been reported. This work investigates nanoparticle (20–200 
nm in diameter) penetration and the effect of ECM integrity 
in a three-dimensional spheroid model.
Fluorescently-labeled, polystyrene beads were used 
as model nanoparticles for these studies because they are 
spherical in shape, as are many nanoparticulate delivery 
vehicles, and they can be obtained in a range of sizes. 
Carboxylate polystyrene beads were chosen because the 
particles can be readily conjugated to targeting ligands for fu-
ture studies (Popielarski et al 2005). The negatively-charged 
beads are also expected to have reduced non-speciﬁ  c bind-
ing of cells, which contain a number of negatively-charged 
membrane components such as proteoglycans (Mislick and 
Baldeschwieler 1996), although non-speciﬁ  c adsorption of 
proteins from the media could signiﬁ  cantly alter the surface 
properties on the nanoparticles once they are added to cell 
cultures. Previous work has shown that the “binding barrier” 
resulting from high afﬁ  nity binding of particles to tissue 
sites immediately after extravasation prevents diffusion into 
deeper tissue (Juweid et al 1992; Graff and Wittrup 2003). 
Nanoparticle penetration was assessed in a three-dimensional 
multicellular spheroid (MCS) model. This model was chosen 
because the MCS can be grown under controlled conditions 
with good reproducibility and homogeneity. MCS are also 
known to produce ECM and to pack with physiologically-
relevant gradients of nutrient accessibility and cell growth 
rates. As a result, MCS have been a valuable model in drug 
penetration studies (Sutherland 1988). 
One major focus in this study was the effect of ECM 
degradation on nanoparticle delivery. Collagenase treatment 
conditions were optimized and the collagen distribution in 
MCS was assessed before and after collagenase treatment. 
Spheroids were treated with 0.1 mg/ml of collagenase 
for 5 h because the kinetics of collagen degradation with 
1.0 mg/ml collagenase was found to be on the order of a few 
hours (Brown et al 2003). In order to retain spheroid integrity 
with a gentler treatment, a lower collagenase concentration 
over a longer time was applied. Collagen staining showed a 
relatively uniform distribution throughout the spheroid. After 
collagenase treatment, very low amounts of collagen were 
detected, especially in the spheroid periphery. 
Nanoparticle penetration into the spheroids was limited 
for all particle sizes tested in the absence of collagenase 
treatment; most nanoparticles remained concentrated at the 
spheroid rim. Although 20 nm and 40 nm nanoparticles 
showed some penetration into the core, this penetration was 
still below 60% of the total spheroid associated nanoparticles. 
This means that the outer cell layers, which represent a 
small portion of the overall volume, contain at least 40% 
of associated nanoparticles. These smaller nanoparticles 
may have transport access because they are small enough to 
diffuse between organized collagen ﬁ  brils. The spacing of 
these ﬁ  brils in tumors has been measured to be 20–40 nm, 
although, larger interﬁ  brillar spacing (75–130 nm) was ob-
served in poorly-organized tumor ECM (Pluen et al 2001). 
The spheroid model used here was relatively tight packed. 
Collagenase treatment increased delivery efﬁ  ciency for 
20, 40, and 100 nm particles. The 20 nm nanoparticles are 
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Figure 8. Penetration of collagenase-coated nanoparticles in multicellular spheroids. 
The penetration of collagenase-coated, 100 nm nanoparticles was quantiﬁ  ed by 
image analysis of spheroid sections and normalized by the integrated ﬂ  uorescence 
signal from spheroids treated with albumin-coated nanoparticles.  Albumin-coated 
beads were incubated with collagenase concentration equivalent to the amount of 
estimated remaining after particle puriﬁ  cation.International Journal of Nanomedicine 2007:2(2) 273
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affected to a lesser extent than 40 nm particles because the 
20 nm particles are better able to diffuse within the spheroid 
in the absence of collagenase. Little improvement in particle 
penetration was observed for particles with diameters above 100 
nm. Collagenase treatment appears to remove most diffusional 
restrictions for the 40 nm particles although transport of the 100 
nm particles into the spheroid is improved only slightly. 
Collagen ﬁ  ber degradation likely increases the accessible 
space in the spheroids for nanoparticle transport, deﬁ  ned as 
the available volume fraction (Kv) (Krol et al 1999; Yuan 
et al 2001). An increase in Kv can improve nanoparticle 
penetration by increasing pore size to allow access of larger 
particles and decreasing frictional resistance to diffusion 
through the pores, by increasing pore connectivity, or by 
reducing torturosity. The importance of these parameters 
in effective drug delivery has been well-covered in the 
literature (Krol et al 1999; Yuan et al 2001; Ramanujan 
et al 2002). 
Upregulated collagenase levels have been associated 
with more aggressive tumors because metalloprotease 
activity is used by migrating and invading cells (Rao 
et al 2005; Xu et al 2005). Therefore, systemic collage-
nase co-treatment and direct injection of collagenase with 
nanoparticles into tumor carries risk due to possible dif-
ferences in the biodistribution of the free enzyme and the 
nanoparticle, leading to a temporal and spatial difference 
in delivery of the two components to the tumor. A more at-
tractive approach is to immobilize the collagenase with the 
nanoparticle to ensure co-delivery. To this end, collagenase 
was immobilized on nanoparticle surfaces by adsorption. 
Collagenase activity was retained by the adsorbed protein, 
and delivery of collagenase-coated, 100 nm nanoparticles 
with active collagenase increases particle penetration by 
4-fold compared with albumin-coated nanoparticles. These 
preliminary results suggest that a nanoparticle delivery 
system, with proper targeting to tumor tissue, could result 
in local delivery of active collagenase leading to increased 
penetration of delivered therapeutics.
The results presented here provide information that 
would be useful for the design of nanoparticle carriers for 
delivery to solid tumors. Carriers 100 nm or larger will 
likely experience a high amount of exclusion from tumor 
tissue, although the surface properties of the particle will 
most likely have a signiﬁ  cant effect on penetration into the 
tumor tissue and warrants further investigation. Reduction 
of collagen in the extracellular matrix can reduce the 
hindrance of previously excluded 100 nm particles, and 
even increase the local concentration of smaller particles 
that are initially relatively free to diffuse in tumor tissue. 
Transmission electron microscopy revealed that, despite the 
presence of a number of large pores between cells, which 
offer a plausible route for particle diffusion, a signiﬁ  cant 
number of tight junctions between cells in the SiHa MCS 
model still remain. Therefore, the use of molecules to 
modify tight junctions may result in similar increases in 
particle penetration to those observed with modulation of 
collagen and may act synergistically with ECM-modulating 
approaches. The covalent conjugation of ECM modulating 
enzymes to therapeutic agents may offer a more stable and 
versatile option compared with adsorption. Recent studies 
have shown that nanoparticles containing covalently linked 
collagenase on their surfaces exhibit improved penetration 
in collagen gels (Kuhn et al 2006). Future studies will 
focus on extending this work beyond model nanoparticles 
to therapeutically relevant nanoparticles and incorporation 
of ECM and/or tight junction-modifying molecules into 
the delivery vehicle for targeted delivery of penetration 
enhancing agents. 
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